By blocking sodium-glucose co-transporter-2 in the kidneys, they promote glucose excretion through urine, effectively lowering blood sugar levels
2022 JAMA Internal Medicine meta-analysis: pooling 76 randomised controlled trials, GLP-1 receptor agonist use was associated with a relative risk of 1.37 for biliary disease compared with placebo or other treatments
DOI: 10.3390/cells10102759 [Google Scholar] Kisseleva T, Brenner D
Minu Liz Mathew, MBBS, MD DVL Chief Dermatologist Dermatology, Cosmetic Dermatology, Lasers & Aesthetic Medicine IADVL ACSI IMA 15+ years 02 Dr
Preclinical findings suggest BPC 157 may influence processes such as angiogenesis, fibroblast activity, and nitric oxide linked pathways, though outcomes depend on model design and study conditions
This means firmer skin, improved structure, and greater resistance to the effects of aging, such as sagging